551. Esketamine in neuropsychiatric long COVID: a retrospective analysis
The International Journal of Neuropsychopharmacology September 1, 2026 N Hartman, D Ivkic, M C Dorczok et al.
Abstract Background Neuropsychiatric manifestations of Long COVID (LC) frequently include post-exertional malaise (Cheng et al., 2025), fatigue, cognitive dysfunction and impairment, sleep disturbances, post-traumatic stress, autonomic dysregulation, pain, inner tension, psychomotor retardation, aberrations in appetite and weight (Badenoch et al., 2022; O'Mahoney et al., 2025), showing...